Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Commercial Officer
-
Stock Symbol
-
BTAI on Nasdaq
Matthew Wiley - trading volume in the past year for BioXcel Therapeutics, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
19K |
$10.5K |
$0.55 |
Oct 3, 2024 |
Direct |
|
|
| Restricted Stock Units |
7.5K |
$9.6K |
$1.28 |
Sep 15, 2024 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.